Mark A. Dawson

18.8k citations
86 papers · 7.5k indexed · 6 hit papers · h-index 33
Topics
Epigenetics and DNA Methylation (21 papers)Protein Degradation and Inhibitors (18 papers)Acute Myeloid Leukemia Research (14 papers)

In The Last Decade

Mark A. Dawson

78 papers receiving 7.4k citations

Hit Papers

Cancer Epigenetics: From Mechanism to Therapy20092026201420202012202020092019202050010001.5k2.0k

Peers

Mark A. Dawson
Comparison fields: 5 of 142
  • Molecular Biology 5.7k
  • Oncology 1.3k
  • Cancer Research 1.2k
  • Hematology 1.2k
  • Genetics 832
Replace Peter Atadja with:
Peter Atadja United States
Joel Johansson United States
Edward A. Fox United States
Dan Grandér Sweden
Domenico Delia Italy
Selina Chen‐Kiang United States
Jordan S. Fridman United States
Henrik Daub Germany
Donald L. Durden United States
Isidro Sánchez‐García Spain
Mark A. Dawson relative to Peter Atadja United States Peter Atadja's profile →
Citations per field
00.5×3.3×
Peter Atadja · 1×
Citations per year

Countries citing papers authored by Mark A. Dawson

Since Specialization
Citations

This map shows the geographic impact of Mark A. Dawson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Dawson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Dawson more than expected).

Fields of papers citing papers by Mark A. Dawson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Dawson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Dawson. The network helps show where Mark A. Dawson may publish in the future.

Co-authorship network of co-authors of Mark A. Dawson

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Dawson. A scholar is included among the top collaborators of Mark A. Dawson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Dawson. Mark A. Dawson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 5
3 7
4 20
5 12
6
Targeting the epigenetic regulation of antitumour immunitybreakdown →
461
7 4
8
Non-genetic mechanisms of therapeutic resistance in cancerbreakdown →
353
9 28
10 74
11
The combination of ibrutinib and venetoclax (ABT-199) rapidly achieves complete remissions in patients with relapsed/refractory mantle cell lymphoma: Preliminary results of the phase II AIM study
3
12 225
13 63
14 41
15 25
16 92
17 100
18 21
19 95
20 5

About Mark A. Dawson

Mark A. Dawson is a scholar working on Hematology, Genetics and Molecular Biology, having authored 86 papers that have together received 7.5k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (21 papers), Protein Degradation and Inhibitors (18 papers) and Acute Myeloid Leukemia Research (14 papers). The work is most often cited by research in Hematology (1.2k citations), Molecular Biology (5.7k citations) and Cancer Research (1.2k citations). Mark A. Dawson has collaborated with scholars based in Australia, United Kingdom and United States. Frequent co-authors include Tony Kouzarides, Andrew J. Bannister, Sarah‐Jane Dawson, Berthold Göttgens, Jean‐Christophe Marine, Ricky W. Johnstone, Paul A. Beavis, Simon J. Hogg, Brian J.P. Huntly and Anthony R. Green. Their work appears in journals such as Nature, Science and New England Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026